Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Huntington's disease | R-HSA-1643685 | 0 | Prestwick-691 | None | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | Prestwick-691 | None | drug-path |
| Parkinson's disease | R-HSA-1643685 | 0 | Prestwick-691 | None | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | Prestwick-691 | None | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | sulfabenzamide | 2265 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | sulfabenzamide | 2265 | drug-path |
| SNARE interactions in vesicular transport | R-HSA-428625 | map04130 | sulfabenzamide | 2265 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | sulfabenzamide | 2265 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfabenzamide | 2265 | drug-path |
| Adipocytokine signaling pathway | R-HSA-168638 | map04920 | sulfabenzamide | 2265 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | sulfabenzamide | 2265 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | sulfabenzamide | 2265 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | BCB000039 | None | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | BCB000039 | None | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | BCB000039 | None | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | BCB000039 | None | drug-path |
| GnRH signaling pathway | R-HSA-168638 | map04912 | BCB000039 | None | drug-path |
| Long-term depression | R-HSA-9620244 | map04730 | BCB000039 | None | drug-path |
| Vascular smooth muscle contraction | R-HSA-445355 | map04270 | BCB000039 | None | drug-path |
| Huntington's disease | R-HSA-1643685 | 0 | BCB000039 | None | drug-path |